Bromazepam

Table of contents

• What is bromazepam?
• How does bromazepam work?
• Which conditions is bromazepam used or studied for?
• How is bromazepam given?
• What do the clinical trials show?
• What side effects are known?

What is bromazepam?

Bromazepam is a medicine that belongs to a group called benzodiazepines, which act on the brain to reduce anxiety and promote calm and sleepiness.^[2] It is used in some countries for the short-term treatment of severe anxiety and panic symptoms in adults.^[2] It is not available in the United States, where other benzodiazepines approved by the FDA, such as diazepam, lorazepam, or alprazolam, are used instead for anxiety or panic disorders.^[2]

Bromazepam is a chemically synthesised substance. In the European Union clinical trial records, it appears as a film-coated tablet for oral use, already authorised as a medicine in Austria.^[1] The authorisation holder is Genericon Pharma Gesellschaft m.b.H., and the product name given is bromazepam Genericon 3 mg Filmtabletten.^[1] Other foreign brand names include Lexotan, Lexomil, and many others listed in international sources.^[2]

How does bromazepam work?

Bromazepam works by acting on the brain to reduce anxiety and promote calm and sleepiness.^[2] In animal studies, bromazepam has shown anti-anxiety, sedative, muscle-relaxant, and anticonvulsant properties.^[2] It is generally prescribed for a short time to relieve severe anxiety or panic symptoms in adults, often while longer-term treatments such as antidepressants or psychological therapies begin to work.^[2]

Which conditions is bromazepam used or studied for?

• Severe anxiety and panic symptoms – bromazepam is used for the short-term treatment of severe anxiety and panic symptoms in adults.^[2]
• Perioperative anxiety and pain – in the clinical trial data, bromazepam is used as a comparator in a trial investigating perioperative anxiety and pain in patients undergoing vitrectomy and/or cataract surgery.^[1]

How is bromazepam given?

Bromazepam is given orally. In the clinical trial records, the pharmaceutical form is a film-coated tablet and the route of administration is oral.^[1] The product name in the trial is bromazepam Genericon 3 mg Filmtabletten, and the dose reported in the trial data is 1.5 mg.^[1]

What do the clinical trials show?

The clinical trial data contains one trial in which bromazepam appears.^[1] The trial is authorised and classified as low intervention.^[1] It enrolled 240 participants undergoing vitrectomy and/or cataract surgery.^[1]

The trial investigates the effect of music on perioperative pain, and the effect of herbal medicine on perioperative pain.^[1] Bromazepam is a comparator in this trial, meaning it is used as a comparison arm rather than being the main substance under investigation.^[1] The primary outcome is the NRS-P score, which measures pain, 30 seconds after retrobulbar block.^[1]

What side effects are known?

Bromazepam has important safety concerns, including dependence, withdrawal, and overdose risks.^[2]